April 6, 2026
NICE Thresholds Drive Better Medicine Access
NICE thresholds now sit at £25,000 to £35,000 per quality-adjusted life year following…
March 30, 2026
Portugal Biotech Gains Global Momentum
Portugal biotech has stepped firmly onto the European stage. The recent BIO-Europe Spring…
March 23, 2026
Companies Strengthen Antimicrobial Access Plans
The shrinking pipeline of new antibiotics makes antimicrobial access a pressing concern for…
March 16, 2026
Redefining Cancer Research Priorities for Maximum Impact
The global oncology landscape is undergoing a necessary strategic shift. Confronted with a…
March 9, 2026
Navigating Cell and Gene Therapy Maturation
The cell and gene therapy (CGT) field has entered a distinct phase of…
March 2, 2026
How Public-Private Rare Disease Partnerships Are Changing Healthcare
An estimated 30 million people in Europe face the complex challenges of a…